Details of the Drug Formulaction

General Information of Drug Formulation (ID: F05854)

• Formulation Name: Didanosine 150 mg tablet
• Company: Aurobindo Pharma

Pharmaceutical Drug(s) in Formulation

Drug Name	Drug ID	Indication	ICD 11	Status
Didanosine	(DMI2QPE)	Human immunodeficiency virus infection	1C62	Approved

Pharmaceutical Excipient(s) in Formulation

Excipient Name	Excipient ID	PubChem CID	Functional Classification
Aspartame	(E00402)	134601	Flavoring agent
Calcium carbonate	(E00198)	10112	Binding agent; Buffering agent; Diluent; Opacifying agent
Crospovidone	(E00626)	Not Available	Disintegrant
Hexahydric alcohol	(E00083)	5780	Diluent; Flavoring agent; Humectant; Plasticizing agent
Magnesium hydroxide	(E00374)	73981	Adsorbent; Buffering agent
Magnesium stearate	(E00208)	11177	lubricant